# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-022034
Filing Date
2024-04-25
Accepted
2024-04-25 16:05:40
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20020644x2_defa14a.htm | DEFA14A | 7757
2 |  | ny20020644x2_pc01.jpg | GRAPHIC | 426742
3 |  | ny20020644x2_pc02.jpg | GRAPHIC | 262983
| Complete submission text file | 0001140361-24-022034.txt |  | 959074

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39402 | Film No.: 24876220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)